Loading…
Kodiak Sciences Inc. is projected to rise to $53.92 by 2027, a +54% move from its current price of $35.09. KOD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $33.87 | $35.11 | $36.39 | +0.05% |
| May 30 | $33.39 | $35.13 | $36.96 | +0.10% |
| May 31 | $33.02 | $35.14 | $37.40 | +0.15% |
| Jun 1 | $32.73 | $35.16 | $37.78 | +0.21% |
| Jun 2 | $32.47 | $35.18 | $38.12 | +0.26% |
| Jun 3 | $32.23 | $35.20 | $38.43 | +0.31% |
| Jun 4 | $32.02 | $35.22 | $38.73 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $32.02 | $35.22 | $38.73 | +0.36% |
| Week 2 | $30.90 | $35.34 | $40.43 | +0.72% |
| Week 3 | $30.09 | $35.47 | $41.81 | +1.08% |
| Week 4 | $29.44 | $35.60 | $43.05 | +1.45% |
| Week 5 | $28.89 | $35.73 | $44.18 | +1.81% |
| Week 6 | $28.41 | $35.85 | $45.25 | +2.18% |
| Week 7 | $27.98 | $35.98 | $46.27 | +2.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company’s preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation.
Kodiak Sciences Inc. (KOD) is the asset with a current price of $36.23 and a market capitalization of $2.27B. It is ranked 1914 in market capitalization. The price outlook is defined by a multi-year forecast that shows growth from 2026 onward, with rising averages and substantial upside in later years.
A major floor 40.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.9% away) — a key level to hold.
The nearest ceiling, 32.3% above — a clean break opens room to run.
A major ceiling 44.4% above — clearing it would confirm fresh momentum.
Key KOD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KOD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $36.19 | Sell | $35.96 | Sell |
| MA 10 | $36.57 | Sell | $36.94 | Sell |
| MA 20 | $39.58 | Sell | $38.42 | Sell |
| MA 50 | $38.42 | Sell | $37.34 | Sell |
| MA 100 | $31.91 | Buy | $33.04 | Buy |
| MA 200 | $24.42 | Buy | $26.30 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.29 | Neutral |
| Stoch RSI (14) | 20.07 | Neutral |
| CCI (20) | -99.08 | Neutral |
| Williams %R (14) | -92.76 | Info |
| MACD (12,26,9) | -0.72 | Sell |
| ROC (12) | -14.44 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 7.24 | Buy |
| TRIX (15) | -0.22 | Sell |
| Awesome (5,34) | -5.25 | Sell |
| Ultimate (7,14,28) | 32.86 | Neutral |
| Momentum (10) | -4.40 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 36.04 | Sell |
| ADX (14) | 18.57 | Neutral |
| ATR (14) | 1.28 | Info |
The near-term technical picture is labeled BULLISH. The RSI(14) is 40, with the 50-day simple moving average at $37.93 and the 200-day simple moving average at $24.15. The 30-day price range spans from $28.27 to $46.43, providing near-term reference points for support and resistance.
Key near-term levels include support at $34.42 and resistance at $46.44, with implied volatility high at 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $21.01 | $35.09 | $46.99 | 0% | Neutral | |
| $41.46 | $53.92 | $75.02 | +54% | Bullish | |
| $50.46 | $68.10 | $99.09 | +94% | Bullish | |
| $52.74 | $73.44 | $110.68 | +109% | Bullish | |
| $58.04 | $83.12 | $129.03 | +137% | Bullish | |
| $61.13 | $89.82 | $143.08 | +156% | Bullish | |
| $66.74 | $100.47 | $163.77 | +186% | Bullish | |
| $80.21 | $123.53 | $205.61 | +252% | Bullish | |
| $97.70 | $153.80 | $260.94 | +338% | Bullish | |
| $108.98 | $175.22 | $302.60 | +399% | Bullish | |
| $168.05 | $297.93 | $553.93 | +749% | Bullish | |
| $223.24 | $472.08 | $976.11 | +12.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $21.01 | $35.09 | $41.27 | +0.00% |
| June 2026 | $29.95 | $35.42 | $43.06 | +0.94% |
| July 2026 | $30.75 | $36.77 | $45.49 | +3.81% |
| August 2026 | $29.80 | $35.95 | $45.07 | -2.24% |
| September 2026 | $28.37 | $34.48 | $43.69 | -4.09% |
| October 2026 | $28.94 | $35.40 | $45.30 | +2.67% |
| November 2026 | $29.75 | $36.60 | $47.25 | +3.41% |
| December 2026 | $29.18 | $36.11 | $46.99 | -1.35% |
Click any year to see its month-by-month KOD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect KOD to range from $21.01 to $46.99 through 2026. The $35.09 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The KOD price prediction for 2027 points to an average of $53.92 (low $41.46, high $75.02) — a potential gain of +54% on today's $35.09. Momentum favours further upside here.
In 2028, KOD is projected to trade between $50.46 and $99.09, averaging $68.10 — a potential gain of +94% from today's $35.09. That is up +26% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Kodiak Sciences Inc.'s 2029 outlook centres on $73.44, within a $52.74 to $110.68 range. That is up +8% on the projected 2028 average. That marks a +109% change versus current levels. Momentum favours further upside here.
By 2030, KOD could reach as high as $129.03, with a base case around $83.12 and support toward $58.04 — roughly +137% from $35.09. Buyers look set to stay in control over this stretch.
Expect KOD to range from $61.13 to $143.08 through 2031. The $89.82 average target implies a +156% move from current prices. That is up +8% on the projected 2030 average. Momentum favours further upside here.
The KOD price prediction for 2032 points to an average of $100.47 (low $66.74, high $163.77) — a potential gain of +186% on today's $35.09. Buyers look set to stay in control over this stretch.
In 2033, KOD is projected to trade between $80.21 and $205.61, averaging $123.53 — a potential gain of +252% from today's $35.09. That is up +23% on the projected 2032 average. Momentum favours further upside here.
Kodiak Sciences Inc.'s 2034 outlook centres on $153.80, within a $97.70 to $260.94 range. That is up +25% on the projected 2033 average. That marks a +338% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, KOD could reach as high as $302.60, with a base case around $175.22 and support toward $108.98 — roughly +399% from $35.09. Momentum favours further upside here.
Expect KOD to range from $168.05 to $553.93 through 2040. The $297.93 average target implies a +749% move from current prices. That is up +70% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The KOD price prediction for 2050 points to an average of $472.08 (low $223.24, high $976.11) — a potential gain of +12.5x on today's $35.09. Momentum favours further upside here.
Investing $1,000 in KOD today (≈ 28.498148 KOD) could be worth
$13,453.32
+$12,453.32 (+1245%) by 2050 · US Dollar
Based on the average projected KOD price of $472.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KODwould be worth at today's price.
$1,000 invested in KOD on May 27, 2025 (≈ 279.329615 KOD) would be worth
$9,801.68
+$8,801.68 (+880.2%) today · 9.80× · US Dollar
Based on a KOD entry price of $3.58 vs. today's $35.09.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $36.22 | $968.8 | -3.1% |
| 1 month ago | $44.11 | $795.51 | -20.4% |
| 3 months ago | $27.98 | $1,254.11 | +25.4% |
| 6 months ago | $22.98 | $1,526.98 | +52.7% |
| 1 year ago | $3.58 | $9,801.68 | +880.2% |
| All time (5.0y) ago | $79.22 | $442.94 | -55.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KOD forecast.
Our base-case forecast reaches $70.00 around 2029.
Implied market cap at $70.00: $4.38B
The multi-year forecast shows a clear bullish trajectory across the horizon. In 2026 the avg is $36.23 with a 0% ROI and NEUTRAL sentiment, followed by stronger upside in subsequent years: 2027 avg $55.91 (ROI 54.3%, BULLISH), 2028 avg $69.78 (ROI 92.6%), 2029 avg $74.01 (ROI 104.3%), 2030 avg $84.76 (ROI 133.9%), 2031 avg $90.07 (ROI 148.6%), 2032 avg $99.13 (ROI 173.6%), 2033 avg $124.18 (ROI 242.8%), 2034 avg $153.58 (ROI 323.9%), 2035 avg $173.73 (ROI 379.5%). The forecast continues with 2040 avg $292.44 (ROI 707.2%) and 2050 avg $452.68 (ROI 1149.5%), both labeled BULLISH.
These figures imply a sustained upside through the 2030s and beyond, though they are estimates, not guarantees, and involve uncertainty and risk.
Tap a question to reveal the answer.
2030 avg $84.76, min $58.47, max $133.22; ROI 133.9%; sentiment BULLISH.
The forecast shows a trajectory toward higher averages and bullish sentiment from 2027 onward, with 2026 at avg $36.23 and ROI 0 (neutral). Long-term figures reach higher prices and double- or triple-digit ROI through 2050, but these are estimates and not guaranteed.
Yes. The forecast shows 2032 max $163.88 and 2033 max $209.76, with 2030 avg $84.76 and 2029 avg $74.01, indicating potential to surpass $100 in the coming years.
Bullish sentiment in the near term. RSI(14) is 40, SMA50 is $37.93, SMA200 is $24.15. The 30-day range is $28.27–$46.43, with support at $34.42 and resistance at $46.44.
Current price is $36.23 and market cap is $2.27B.
Kodiak Sciences Inc. Community Discussion
0Share your Kodiak Sciences Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.